The new data highlight the potential of AstraZeneca’s innovative therapies to improve outcomes across multiple cancer types
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
Datroway becomes the first and only therapy to show overall survival benefit versus chemotherapy in this difficult-to-treat patient population
_LOGO_256_384.jpg){kind=logo}
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6-directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
Subscribe To Our Newsletter & Stay Updated
